Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
25.31
-0.36 (-1.40%)
At close: Feb 21, 2025, 4:00 PM
25.25
-0.06 (-0.24%)
After-hours: Feb 21, 2025, 5:42 PM EST
Surgery Partners Market Cap
Surgery Partners has a market cap or net worth of $3.20 billion as of February 21, 2025. Its market cap has decreased by -22.33% in one year.
Market Cap
3.20B
Enterprise Value
6.48B
1-Year Change
-22.33%
Ranking
Category
Stock Price
$25.31
Market Cap Chart
Since October 1, 2015, Surgery Partners's market cap has increased from $872.10M to $3.20B, an increase of 266.79%. That is a compound annual growth rate of 14.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 21, 2025 | 3.22B | 19.55% |
Dec 31, 2024 | 2.69B | -33.50% |
Dec 29, 2023 | 4.05B | 61.47% |
Dec 30, 2022 | 2.51B | -43.08% |
Dec 31, 2021 | 4.40B | 200.56% |
Dec 31, 2020 | 1.46B | 89.02% |
Dec 31, 2019 | 775.00M | 61.93% |
Dec 31, 2018 | 478.60M | -18.90% |
Dec 29, 2017 | 590.10M | -23.22% |
Dec 30, 2016 | 768.60M | -22.10% |
Dec 31, 2015 | 986.70M | 13.14% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 788.19B |
UnitedHealth Group | 464.25B |
Johnson & Johnson | 384.16B |
Novo Nordisk | 370.06B |
AbbVie | 352.22B |
Abbott Laboratories | 230.14B |
AstraZeneca | 228.16B |
Merck & Co. | 219.67B |